C5-Alkyl-2-methylurea-Substituted Pyridines as a New Class of Glucokinase Activators-Reference-Cited by-同舟云学术

C5-Alkyl-2-methylurea-Substituted Pyridines as a New Class of Glucokinase Activators

Published:2014-11-26 Issue:12 Volume:5 Page:1284-1289
ISSN:1948-5875
Container-title:ACS Medicinal Chemistry Letters
language:en
Short-container-title:ACS Med. Chem. Lett.

Author:

Du Xiaohui¹,Hinklin Ronald J.²,Xiong Yumei¹,Dransfield Paul¹,Park Jaehyeon¹,Kohn Todd J.¹,Pattaropong Vatee¹,Lai SuJen¹,Fu Zice¹,Jiao Xianyun¹,Chow David¹,Jin Lixia¹,Davda Jasmine¹,Veniant Murielle M.³,Anderson Deborah A.²,Baer Brian R.²,Bencsik Josef R.²,Boyd Steven A.²,Chicarelli Mark Joseph²,Mohr Peter J.²,Wang Bin²,Condroski Kevin R.²,DeWolf Walter E.²,Conn Marion¹,Tran Thanhvien¹,Yang Jerry¹,Aicher Thomas D.²,Medina Julio C.¹,Coward Peter¹,Houze Jonathan B.¹

Affiliation:

1. Amgen, Inc., 1120 Veterans Boulevard, South San Francisco, California 94080, United States

2. Array BioPharma, 3200 Walnut Street, Boulder, Colorado 80301, United States

3. Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320, United States

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Drug Discovery,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/ml500341w

Reference22 articles.

1. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants